Revised Guidelines on BSE Will Become Effective Next April

Published: 2004-12-29 06:56:00

Updated: 2004-12-29 06:56:00

The Korea Food and Drug Administration (KFDA) announced on December 28th of its revised guidelines addressed to the pharmaceutical manufacturers and importers handling bovine-derived materials intended for human use, to further strengthen the safety measures for Bovine Spongiform Encephalopathy (...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK